69 related articles for article (PubMed ID: 15276379)
1. IGF-1, IGFBP-3, and cancer risk.
Schott M; Seissler J; Scherbaum WA
Lancet; 2004 Jul 24-30; 364(9431):325; author reply 326-7. PubMed ID: 15276379
[No Abstract] [Full Text] [Related]
2. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors].
Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U
Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158
[TBL] [Abstract][Full Text] [Related]
3. Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia.
Dawczynski K; Kauf E; Zintl F
Bone Marrow Transplant; 2003 Aug; 32(4):411-5. PubMed ID: 12900778
[TBL] [Abstract][Full Text] [Related]
4. [Changes in concentrations of circulating insulin-like growth factors I and II and binding proteins BP-2 and BP-3 in children treated for acute lymphoblastic leukaemia].
Krawczuk-Rybak M; Kitszel A; Wołczyński S
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):15-20. PubMed ID: 15355735
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia.
Petridou E; Skalkidou A; Dessypris N; Moustaki M; Mantzoros C; Spanos E; Trichopoulos D
Oncology; 2001; 60(3):252-7. PubMed ID: 11340377
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels of insulin-like growth factor-1 and growth factor binding protein-3 in children with acute lymphocytic leukemia].
Zhao DJ; Zhang WL; Shi TX
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Feb; 13(2):101-3. PubMed ID: 21342615
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis.
van der Lely AJ; de Herder WW; Janssen JA; Lamberts SW
J Endocrinol; 1997 Oct; 155 Suppl 1():S9-13; discussion S15-6. PubMed ID: 9389990
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion.
Rasat R; Livesey JL; Espiner EA; Abbott GD; Donald RA
N Z Med J; 1996 May; 109(1021):156-9. PubMed ID: 8657365
[TBL] [Abstract][Full Text] [Related]
10. IGF-1, IGFBP-3, and cancer risk.
Holly J
Lancet; 2004 Jul 24-30; 364(9431):325-6; author reply 326-7. PubMed ID: 15276380
[No Abstract] [Full Text] [Related]
11. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
Wass JA
J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
16. Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
Kitszel A; Krawczuk-Rybak M
Adv Med Sci; 2007; 52():147-53. PubMed ID: 18217408
[TBL] [Abstract][Full Text] [Related]
17. IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
Akin F; Turgut S; Cirak B; Kursunluoglu R
Growth Horm IGF Res; 2010 Dec; 20(6):399-403. PubMed ID: 20920870
[TBL] [Abstract][Full Text] [Related]
18. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
